References
- Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Teacher D. F., Turner R. C. Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412–19
- Salvarani C., Gabriel S. E., O'Fallon W. M., Hunder G. G. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970–1991. Arthritis Rheum 1995; 38: 369–73
- Cimmino M. A. Genetic and environmental factors in polymyalgia rheumatica. Ann Rheum Dis 1997; 56: 576–7
- Cantini F., Salvarani C., Olivieri I., Niccoli L., Padula A., Macchioni L., et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case–control study. J Rheum 2001; 28: 1049–55
- Cantini F., Salvarani C., Olivieri I., Macchioni L., Ranzi A., Niccoli L., et al. Erythrocyte sedimentation rate and C‐reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow‐up study. Semin Arthritis Rheum 2000; 30: 17–24
- Choi K. M., Lee K. W., Kim S. G., Kim N. H., Park C. G., Seo H. S., et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 2005; 90: 175–80
- Nesto R. C‐reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones. Diabet Med 2004; 21: 810–17